Non-linear dynamics models characterizing long-term virological data from AIDS clinical trials

Mathematical Biosciences

Volumn 176, Issue 2, 2002, Pages 163-183

  Verotta, Davide ^a,b   Schaedeli, Franziska ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Anti retroviral drug therapy; HIV dynamics; Linearized models; Mixed effect; Non linear models

Indexed keywords

CELLS; COMPUTER SIMULATION; DRUG THERAPY; IMMUNIZATION;

CLINICAL TRIALS;

VIRUSES;

ANTIRETROVIRUS AGENT;

HUMAN IMMUNODEFICIENCY VIRUS; PREDATOR-PREY INTERACTION;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CLINICAL TRIAL; DYNAMICS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MATHEMATICAL MODEL; NONLINEAR SYSTEM; PATIENT COMPLIANCE; PREDATOR PREY INTERACTION; T LYMPHOCYTE; VIRUS CELL INTERACTION; VIRUS LOAD; VIRUS REPLICATION;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ANTI-HIV AGENTS; HIV-1; HUMANS; LONGITUDINAL STUDIES; MODELS, BIOLOGICAL; NONLINEAR DYNAMICS; PATIENT COMPLIANCE; VIRAL LOAD;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0036229527     PISSN: 00255564     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0025-5564(02)00090-1     Document Type: Article

References (38)

1. Coexistence and competition in HIV infections
2. Mathematical biology of HIV infections: Antigenetic variation and diversity threshold
3. Anti-viral drug treatment: Dynamics of resistance in free virus and infected cell population
4. Competitive coexistence in antiviral immunity
5. Mathematical analysis of antiretroviral therapy aimed at HIV-1 eradication or maintenance of low viral loads
6. Modeling plasma virus concentration during primary HIV infection
7. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection
8. Viral dynamics in human immunodeficiency virus type 1 infection
9. HIV-1 dynamics in vivo: Virion clearance rate, infected cell life-span, and viral generation time
10. Decay characteristics of HIV-1-infected compartments during combination therapy
11. Estimation of HIV dynamic parameters
12. Population HIV-1 dynamics in vivo: Applicable models and inferential tools for virological data from AIDS clinical trials
13. A.-D.C.C.A.H.-1.D.R viral, replication under highly active antiretroviral therapy
14. Physiologic indirect response models characterize diverse types of pharmacodynamic effects
15. A general semi-parametric model for non-steady-state pharmacokinetic and pharmacodynamic data
16. A general conceptual model for non-steady state pharmacokinetic/pharmacodynamic data
17. The dynamics of drug action on the within-host population growth of infectious agents: Melding pharmacokinetics with pathogen population dynamics
18. Adherence and drug resistance: Predictions for therapy outcome
19. Population dynamics of immune response to persistent viruses
20. Human immunodeficiency virus drug therapy and virus load
21. Identifiability of compartmental systems and related structural properties
22. Numerical parameter identifiability and estimability: Integrating identifiability, estimability, and optimal sampling design
23. Compliance as an explanatory variable in clinical trial
24. Contending paradigms for the interpretation of data on patient compliance with therapeutic drug regimens
25. Semiparametric models for drug interactions
26. The population approach to pharmacokinetic data analysis: Rationale and standard data analysis methods
27. Rational transfer function approximation
28. A new look at the statistical model identification problem
29. The non-linear mixed effect model with a smooth random effects density
30. Global identifiability of non-linear models of biological systems
31. Parameter and structural identifiability concepts and ambiguities: A critical review and analysis
32. Latent infection of CD4 + T-cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination
33. Potential mechanism for sustained artiretroviral efficacy of AZT-3TC combination therapy